Skip to main content
OGI logo

Organigram Global Inc. (OGI) Stock Price & Analysis

Organigram Global Inc. (OGI) — MoonshotScore 35/100 (Weak band), calculated Nov 18, 2026. Price $0.6296 (-6.95%), as of the Nov 19, 2026 trading session; market cap $88.9M.

Educational signal · not a buy or sell recommendation · How to read this

$0.6296 −$0.047 (-6.95%) Market Cap $88.9M

Organigram Global Inc. · OGI · NASDAQ

Organigram Global Inc. is a Canadian cannabis company focused on producing and selling a diverse range of cannabis and cannabis-derived products. They operate in both the medical and recreational markets, offering various brands and product formats.

Price as of Nov 19, 2026

Key Statistics

35 of 100

MoonshotScore v2 · Organigram Global (OGI)

Weak
Business Quality Solid (60)
Financial Safety Strained (38)
Valuation Cheap (86)
Growth Durability Growing (72)
Momentum Slipping (32)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Durable growth, at a cheap price, but a strained balance sheet. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and reported profit not backed by cash flow. Business Quality: Solid; Financial Safety: Strained; Valuation: Cheap; Growth Durability: Growing; Momentum: Slipping.

  • EPS beat 4 of the last 8 reports
  • Altman Z 0.10 · Piotroski F 5
  • ROE 22.0% · ROA 10.6% · current ratio 2.61 · earnings yield 54.3% · free-cash-flow yield -17.5%

Holding back: weak price trend

Helping: an attractive price, durable growth

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for OGI (52 recorded, newest six shown)
RecordedScoreBand
34Weak
34Weak
34Weak
34Weak
35Weak
35Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.6296
Change on the day-6.95%
Market capitalisation$88.9M—
Price / earnings (trailing)1.59
Shares traded on the day1.37M

Price & events

Other perspectives

Council score for Organigram Global (OGI): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Weak
Valuation Strong
Growth Durability Moderate
Momentum Weak

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Undervalued
Profit Margin Strong
Debt/Equity Strong
ROE Strong
Gross Margin Neutral

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Organigram Global (OGI), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Organigram Global Inc. (OGI) is listed on NASDAQ. It employs 1,139 people. The market values it at $88.9M.

2 · Latest results

What do the latest results show for Organigram Global (OGI)?

Short answer · as of

Against analyst estimates the company has EPS beat 4 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Jun 2025C$71M-C$6M-C$0.05 (diluted)
Q4 FY2025C$80M-C$38M—
Q1 FY2026C$64MC$20MC$0.15 (diluted)
Q2 FY2026C$60M-C$921,000-C$0.01 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Organigram Global (OGI)?

Short answer · as of

The MoonshotScore pillars rate an attractive price, durable growth as strengths. What is holding it back is weak price trend. The distress and quality screens read Altman Z 0.10 · Piotroski F 5. Trailing ratios: ROE 22.0% · ROA 10.6% · current ratio 2.61 · earnings yield 54.3% · free-cash-flow yield -17.5%.

Data-derived red flags

  • Listing risk — at $0.6296 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
  • Financial-distress signal — its Altman Z-Score of 0.10 sits in the distress zone (elevated bankruptcy risk).
5 · Peer comparison

How does Organigram Global compare with its peers?

Short answer

Organigram Global's score ranks 4th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Cumberland Pharmaceuticals Inc. (CPIX) Same industry, near in market value$6.57 Nov 18, 2026$98.5M51 5-pillar Nov 18, 2026
Cardiol Therapeutics Inc. (CRDL) Same industry, near in market value$0.88 Nov 19, 2026$113M49 5-pillar Nov 18, 2026
SIGA Technologies, Inc. (SIGA) Same industry, near in market value$2.65 Nov 19, 2026$190M38 5-pillar Nov 18, 2026
Organigram Global (OGI) — this page$0.6296$88.9M35
Zhengye Biotechnology Holding Limited (ZYBT) Same industry, near in market value$1.50 Nov 18, 2026$71.1M32 5-pillar Nov 18, 2026
SNDL Inc. (SNDL) Same industry, near in market value$1.24 Nov 19, 2026$302M32 5-pillar Nov 18, 2026
Journey Medical Corporation (DERM) Same industry, near in market value$3.55 Nov 19, 2026$100M31 5-pillar Nov 18, 2026
Talphera, Inc. (TLPH) Same industry, near in market value$0.74 Nov 19, 2026$38.4M31 5-pillar Nov 18, 2026
Organogenesis Holdings Inc. (ORGO) Same industry, near in market value$0.85 Nov 18, 2026$111M28 5-pillar Nov 18, 2026
Aytu BioPharma, Inc. (AYTU) Same industry, near in market value$2.66 Nov 18, 2026$28.9M25 5-pillar Nov 18, 2026
Emergent BioSolutions Inc. (EBS) Same industry, near in market value$5.15 Nov 19, 2026$265M24 5-pillar Nov 18, 2026
SCYNEXIS, Inc. (SCYX) Same industry, near in market value$2.60 Nov 19, 2026$25.9M23 5-pillar Nov 18, 2026
Lifecore Biomedical, Inc. (LFCR) Same industry, near in market value$6.37 Nov 19, 2026$241M21 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held OGI in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported OGI in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Organigram Global (OGI)?

Read these with our analysis →

What Investors Ask About Organigram Global (OGI)

These answers are editorial: 1 of these 9 answers is drawn from the OGI research dossier (written May 5, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for OGI?

OGI carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is OGI a good stock to buy?

Stock Expert AI does not rate OGI buy, sell or hold. Organigram Global Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the OGI stock price today?

The last price recorded for Organigram Global Inc. (OGI), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What does Organigram Global Inc. do?

Organigram Global Inc. is a Canadian cannabis company that cultivates, produces, and sells a range of cannabis and cannabis-derived products. These products include dried flower, oils, edibles, and concentrates, catering to both the medical and recreational markets.

What are the key factors to evaluate for OGI?

Organigram Global Inc. (OGI) holds a MoonshotScore in the low range. To weigh it, start with the trailing P/E under Price & valuation on this page. Not financial advice.

How frequently does OGI data refresh on this page?

OGI's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven OGI's recent stock price performance?

Organigram Global Inc. (OGI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider OGI overvalued or undervalued right now?

The trailing P/E of Organigram Global Inc. (OGI) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of OGI?

Fractional-share availability for Organigram Global Inc. (OGI) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 5, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 11 figures on this page — 6 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.